Frontiers in cellular and infection microbiology · 2026
Taraxacum alleviates ulcerative colitis, accompanied by the modulation of gut microbiota and restoration of intestinal barrier integrity.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Fu Chunsheng, Chen Zheyu, Xu Chensen, Hua Huilian, Ye Jun
Аннотация
BACKGROUND: Previous studies have shown that Taraxacum(TM) possesses strong antioxidant, anti-inflammatory, and antibacterial activities, but the mechanism regarding how TM attenuates IBD requires further exploration. This study evaluated the therapeutic effects of TM (0.15, 0.75, and 1.5 g/kg) on ulcerative colitis induced by Dextran Sulfate Sodium (DSS) in mice.
RESULTS: After 14 days of treatment following colitis induction, the herbal extract alleviated body weight loss and pathological abnormalities in the mice. In comparison to the DSS group, the 1.5 g/kg The TM therapy group had markedly elevated levels of colonic T-SOD, T-AOC, and GSH-Px (P < 0.05), alongside a substantial decrease in MDA content (P < 0.05) and inflammatory cytokines (IL-2, IL-6, IFN-g, TNF-a) (P < 0.05). Furthermore, TM markedly elevated the concentrations of volatile fatty acids (acetate, propionate, isobutyrate, and butyrate) in the cecal contents (P < 0.05). The 0.75 and 1.5 g/kg TM groups also elevated the expression of Claudin-1, Occludin, and ZO-1 (P < 0.05), whereas the DSS group showed reduced expression of these mucosal barrier proteins. Concerning gut microbiota, at the Phylum level, the relative abundance of Firmicutes was markedly elevated in the 1.5 g/kg TM groups (P < 0.05), Bacteroidetes exhibited a considerable reduction (P < 0.05); TM alleviated colitis concurrent with the restoration of beneficial Muribaculaceae and reduction of harmful Desulfovibrio. Notably, Desulfovibrio was inhibited more effectively than in 5-ASA, a change associated with intestinal homeostasis.
CONCLUSION: TM alleviated colitis is correlated with enhancing antioxidant capacity, reducing inflammation, restoringbarrier integrity, and modulating the gut microbiota.
RESULTS: After 14 days of treatment following colitis induction, the herbal extract alleviated body weight loss and pathological abnormalities in the mice. In comparison to the DSS group, the 1.5 g/kg The TM therapy group had markedly elevated levels of colonic T-SOD, T-AOC, and GSH-Px (P < 0.05), alongside a substantial decrease in MDA content (P < 0.05) and inflammatory cytokines (IL-2, IL-6, IFN-g, TNF-a) (P < 0.05). Furthermore, TM markedly elevated the concentrations of volatile fatty acids (acetate, propionate, isobutyrate, and butyrate) in the cecal contents (P < 0.05). The 0.75 and 1.5 g/kg TM groups also elevated the expression of Claudin-1, Occludin, and ZO-1 (P < 0.05), whereas the DSS group showed reduced expression of these mucosal barrier proteins. Concerning gut microbiota, at the Phylum level, the relative abundance of Firmicutes was markedly elevated in the 1.5 g/kg TM groups (P < 0.05), Bacteroidetes exhibited a considerable reduction (P < 0.05); TM alleviated colitis concurrent with the restoration of beneficial Muribaculaceae and reduction of harmful Desulfovibrio. Notably, Desulfovibrio was inhibited more effectively than in 5-ASA, a change associated with intestinal homeostasis.
CONCLUSION: TM alleviated colitis is correlated with enhancing antioxidant capacity, reducing inflammation, restoringbarrier integrity, and modulating the gut microbiota.